Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: A hypothesis

References

• Lowell C A, Potter D A, Stearman R S, Morrow J F. Structure of the murine serum amyloid A gene family. Gene conversion. J Biol Chem 1986; 261: 8442–8452
   PubMed Web of Science ®Google Scholar
• Benditt E P, Meek R L. Expression of the third member of the serum amyloid A gene family in mouse adipocytes. J Exp Med 1989; 169: 1841–1846
   PubMed Web of Science ®Google Scholar
• Rokita H, Shirahama T, Cohen A S, Meek R L, Benditt E P, Sipe J D. Differential expression of the amyloid SAA gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes. J Immunol 1987; 139: 3849–3853
   PubMed Web of Science ®Google Scholar
• Sipe J D. Serum amyloid A protein classification: A preliminary report of a subcommittee of the International Society of Amyloidosis. Amyloid 1995; 2: 69–70
   Web of Science ®Google Scholar
• Whitehead A S, de Beer M C, Steel D M, Rits M, Lelias J M, Lane W S, de Beer F C. Identification of novel members of the serum amyloid-A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992; 267: 3862–3867
   PubMed Web of Science ®Google Scholar
• Meek R L, Eriksen N, Benditt E P. Murine serum amyloid-A(3) is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci USA 1992; 89: 7949–7952
   PubMed Web of Science ®Google Scholar
• Urieli-Shoval S, Meek R L, Hanson R H, Eriksen N, Benditt E P. Human serum amyloid a genes are ex-pressed in monocyte/macrophage cell lines. Amer J Pathol 1994; 145: 650–660
   PubMed Web of Science ®Google Scholar
• Kushner I, Rzewnicki D L. The acute phase response: general aspects. Clinical Rheumatology: Vol. 8 No. 3, Reactive Amyloidosis and the Acute Phase Response, G Husby. Bailliere Tindall, London 1994; 513–530
   Google Scholar
• Edbrooke M R, Burt D W, Cheshire J K, Woo P. Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor kB-like transcription factor. Mol Cell Biol 1989; 9: 1908–1916
   PubMed Web of Science ®Google Scholar
• Edbrooke M R, Foldi J, Cheshire J K, Li F, Faulkes D J, Woo P. Constitutive and NF-kappaB Like Proteins in the Regulation of the Serum Amyloid-A Gene by Interleukin-l. Cytokine 1991; 3: 380–388
   PubMed Web of Science ®Google Scholar
• Betts J C, Cheshire J K, Akira S, Kishimoto T, Woo P. The Role of NF-kappa B and NF-IL6 Transactivating factors in the synergistic activation of human serum amyloid-A gene expression by interleukin-1 and interleukin-6. J Biol Chem 1993; 268: 25624–25631
   PubMed Web of Science ®Google Scholar
• Ray A, Ray B K. Serum amyloid A gene expression under acute-phase conditions involves participation of inducible C/EBP-beta and C/EBP-delta and their activation by phosphorylation. Mol Cell Biol 1994; 14: 4324–4332
   PubMedGoogle Scholar
• Brissette L, Young I, Narindrasorasak S, Kisilevsky R, Deeley R. Differential induction of the serum amyloid-A gene family in response to an inflammatory agent and to amyloid-enhancing factor. J Biol Chem 1989; 264: 19327–19332
   PubMed Web of Science ®Google Scholar
• Morrow J F, Stearman R S, Peltzman C G, Potter D A. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA 1981; 78: 4718–4722
   PubMed Web of Science ®Google Scholar
• McAdam KPWJ, Sipe J D. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med 1976; 144: 1121–1127
   PubMed Web of Science ®Google Scholar
• McAdam KPWJ, Elin R J, Sipe J D, Wolff S M. Changes in human serum amyloid-A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest 1978; 61: 390–394
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Boudreau L, Foster D. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy. Lab Invest 1983; 48: 60–67
   PubMed Web of Science ®Google Scholar
• van der Westhuyzen D R, Coetzee G A, de Beer F C. Serum amyloid A protein in plasma: characteristics of acute phase HDL. Amyloidosis, J Marrink, M H Van Rijswijk. Martinus Nijhoff, Dordrecht 1986; 115–125
   Google Scholar
• Benson M D, Aldo-Benson M A. SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Immunol 1982; 128: 2390–2392
   PubMed Web of Science ®Google Scholar
• Benson M D, Aldo-Benson M A, Shirahama T, Borel Y, Cohen A S. Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis. J Exp Med 1975; 142: 236–241
   PubMed Web of Science ®Google Scholar
• Benson M D, Aldo-Benson M. Effect of purified protein SAA on immune response in vitro: mechanisms of suppression. J Immunol 1979; 122: 2077–2082
   PubMed Web of Science ®Google Scholar
• Brinckerhoff C E, Mitchell T I, Karmilowicz M J, Kluve-Beckerman B, Benson M D. Autocrine induction of collagenase by serum amyloid A-like and β2-microglobulin-like proteins. Science 1989; 243: 655–656
   PubMed Web of Science ®Google Scholar
• Sack G H, Talbot C C. The Human Serum Amyloid-A (SAA)-Encoding Gene Gsaal-nucleotide sequence and possible autocrine-collagenase-inducer function. Gene 1989; 84: 509–515
   PubMed Web of Science ®Google Scholar
• Mitchell T I, Coon C I, Brinckerhoff C E. Serum amyloid-A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin-1 induces synthesis of collagenase and is neutralized with specific antiserum. J Clin Invest 1991; 87: 1177–1185
   PubMed Web of Science ®Google Scholar
• Mitchell T I, Jeffrey J J, Palmiter R D, Brinckerhoff C E. The acute phase reactant serum amyloid-A(SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim Biophys Acta 1993; 1156: 245–254
   PubMedGoogle Scholar
• Linke R P, Bock V, Valet G, Rothe G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem Biophys Res Commun 1991; 176: 1100–1105
   PubMed Web of Science ®Google Scholar
• Badolato R, Wang J M, Murphy W J, Lloyd A R, Michiel D F., Bausserman L L, Kelvin D J, Oppenheim J J. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994; 180: 203–209
   PubMed Web of Science ®Google Scholar
• Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4(+) T cells. J Imrnunol 1996; 156: 1189–1195
   PubMed Web of Science ®Google Scholar
• Goldfarb D, Nathan I, Dvilansky A, Khoda G, Shainkin-Kestenbaum R. Modulation of transformed cells by serum amyloid-A interaction with TPA. Cancer J 1991; 4: 35–38
   Web of Science ®Google Scholar
• Preciado-Patt L, Levartowsky D, Pras M, Hershkoviz R, Lider O, Fridkin M. Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A - Toward understanding the physiological role of an enigmatic protein. Eur J Biochem 1994; 223: 35–42
   PubMedGoogle Scholar
• Assmann G, Funke H. HDL Metabolism and Atherosclerosis. J Cardiovasc Pharmacol 1990; 16: S15–S20
   PubMed Web of Science ®Google Scholar
• Vanlenten B J, Hama S Y, de Beer F C, Stafforini D M, McIntyre T M, Prescott S M, Ladu B N, Fogelman A M, Navab M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response - Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995; 96: 2758–2767
   PubMed Web of Science ®Google Scholar
• Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart J C. Influence of serum amyloid-A on cholesterol esterification in human plasma. Biochim Biophys Acta 1989; 1006: 173–178
   PubMed Web of Science ®Google Scholar
• Fielding C J, Fielding P E. Molecular physiology of reverse cholesterol transport - Review. J Lipid Res 1995; 36: 211–228
   PubMed Web of Science ®Google Scholar
• Parks J S, Li H, Gebre A K, Smith T L, Maeda N. Effect of apolipoprotein A-I deficiency on lecithin: cholesterol acyltransferase activation in mouse plasma. J Lipid Res 1995; 36: 349–355
   PubMed Web of Science ®Google Scholar
• Husby G, Marhaug G, Dowton B, Sletten K, Sipe J D. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid lnt J Exp Clin Invest 1994; 1: 118–137
   Web of Science ®Google Scholar
• Marhaug G, Dowton S B. Serum amyloid A: An acute phase apolipoprotein and the precursor of AA amyloid. Clinical Rheumatology: Vol. 8 No. 3, Reactive Amyloidosis and the Acute Phase Response, G Husby. Bailliere Tindall, London 1994; 553–573
   Google Scholar
• Ericsson L H, Eriksen N, Walsh K A, Benditt E P. Primary structure of duck amyloid protein A: The form deposited in tissues may be identical to its serum precursor. FEBS Lett 1987; 218: 11–16
   PubMed Web of Science ®Google Scholar
• Syversen P V, Juul J, Marhaug G, Husby G, Sletten K. The primary structure of serum amyloid-A protein in the sheep-comparison with serum amyloid-A in other species. Scand J Immunol 1994; 39: 88–94
   PubMed Web of Science ®Google Scholar
• Fantone J C, Ward P A. Inflammation. Pathology, E Rubin, J Farber, Philadelphia, Lippincott 1994; 32–67
   Google Scholar
• Macchia T, Mancinelli R, Barbini D A, Taggi F, Avico U, Cantafora A. Determination of membrane cholesterol in normal and pathological red blood cells. Clin Chin Acta 1991; 199: 59–67
   PubMed Web of Science ®Google Scholar
• Cooper R A. Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells. J Supramol Struct 1978; 8: 413–430
   PubMedGoogle Scholar
• Mindham M A, Mayes P A. Reverse cholesterol transport in the rat - studies using the isolated perfused spleen in conjunction with the perfused liver. Biochem J 1991; 279: 503–508
   PubMed Web of Science ®Google Scholar
• Glomset J A. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res 1968; 9: 155–167
   PubMed Web of Science ®Google Scholar
• Mindham M A, Mayes P A. Application of simultaneous spleen and liver perfusion to the study of reverse cholesterol transport. Biochem J 1994; 302: 207–213
   PubMed Web of Science ®Google Scholar
• Mindham M A, Mayes P A, Miller N E. Reverse cholesterol transport in the isolated perfused rat spleen. Biochem J 1990; 268: 499–505
   PubMed Web of Science ®Google Scholar
• Jiao S, Cole T G, Kitchens R T, Pfleger B, Shonfeld G. Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel permeation chromatography. Metabolism 1990; 39: 155–160
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity: a clue to serum amyloid A's principal function. Lab Invest 1992; 66: 778–785
   PubMed Web of Science ®Google Scholar
• Banka C L, Yuan T, de Beer M C, Kindy M, Curtiss L K, de Beer F C. Serum amyloid A (SAA): Influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995; 36: 1058–1065
   PubMed Web of Science ®Google Scholar
• Elliott-Bryant R, Sipe J D, Gonnerman W A, Newcombe D, Cathcart E S. In-vitro clearance of HDL associated SAA by resident peritoneal cells from CBA/J mice. Amyloid and Amyloidosis 1993, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. Parthenon Publishing Group Inc., Pearl River, NY 1994; 119–121
   Google Scholar
• Lavie G, Zucker-Franklin D, Franklin E C. Degradation of serum amyloid A protein by surface associated enzymes of human blood monocytes. J Exp Med 1978; 148: 1020–1031
   PubMed Web of Science ®Google Scholar
• Lavie G, Zucker-Franklin D, Franklin E C. Elastase-type proteases on the surface of human blood monocytes possible role in amyloid formation. J Immunol 1980; 125: 175–180
   PubMed Web of Science ®Google Scholar
• Yamada T, Liepnieks J J, Kluve-Beckerman B, Benson M D. Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A. Scand J Immunol 1995; 41: 94–97
   PubMed Web of Science ®Google Scholar
• Yamada T, Kluve-Beckerman B, Liepnieks J J, Benson M D. In vitro degradation of serum amyloid A by Cathepsin D and other acid proteases: Possible protection against amyloid fibril formation. Scand J Immunol 1995; 41: 570–574
   PubMed Web of Science ®Google Scholar
• Mayes P A. Cholesterol synthesis, transport, and excretion. Harpers Biochemistry, R K Murray, D K Granner, P A Mayes, V W Rodwell. Appleton & Lange, Norwalk, Conn 1993; 266–278
   Google Scholar
• Liang J S, Sipe J D. Recombinant human serum amyloid A [apoSAA(p)] binds cholesterol and modulates cholesterol flux. J Lipid Res 1995; 36: 526–533
   PubMed Web of Science ®Google Scholar
• Liang H Q, Rye K A, Barter P J. Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim Biophys Acta 1995; 1257: 31–37
   PubMed Web of Science ®Google Scholar
• Meek R L, Benditt E P. Rat tissues express serum amyloid A protein-related mRNAs. Proc Nat Acad Sci USA 1989; 86: 1890–1894
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Subrahmanyan L. Serum amyloid A influences the efflux of cholesterol from macrophages. Amyloid and Amyloidosis 1993, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. The Parthenon Publishing Group, Park Ridge, New Jersey 1994; 115–118
   Google Scholar